Viewing Study NCT00509392


Ignite Creation Date: 2025-12-24 @ 3:23 PM
Ignite Modification Date: 2026-01-26 @ 7:19 AM
Study NCT ID: NCT00509392
Status: COMPLETED
Last Update Posted: 2017-07-12
First Post: 2007-07-27
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study.
Sponsor: Medtronic Endovascular
Organization:

Study Overview

Official Title: Radiofrequency Endovenous ClosureFAST vs. Laser Ablation for the Treatment of Great Saphenous Reflux: A Multicenter, Single-Blinded, Randomized Study (RECOVERY)
Status: COMPLETED
Status Verified Date: 2017-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RECOVERY
Brief Summary: The objective of this post-market study is to compare the post-procedure recovery between two types of minimally invasive catheter treatments for venous disease in the Great Saphenous Vein.
Detailed Description: Comparison of the post-procedure recovery of radiofrequency (RFA) treatment vs. laser treatment.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: